The Washington Times Daily : 2019-02-11

NATION : 3 : A3


| A3 NATION MONDAY, FEBRUARY 11, 2019 R ☆ Protected Classes Protect HIV Patients Today, HIV is no longer a death sentence thanks to antiretroviral medications. These life-saving treatments allow people living with HIV to enjoy long, healthy lives and reduce the chance of transmitting the disease to others. As one of Medicare’s six protected drug classes, antiretrovirals are now under attack. The new proposed rule by the Administration – Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses – would substantively damage the way antiretrovirals are covered under Medicare Part D. It would reduce the number of medications available and force prescribers to navigate burdensome obstacles that will delay and possibly block patients’ access to some prescribed treatments. Prescribing less than optimal therapy has long-term negative health consequences. HIV care providers need all of the available treatment options to keep HIV patients healthy and reduce transmission. This rule change will have a devastating effect. At least 25% of all people living with HIV in the U.S. rely on Medicare as their insurer. Their access to life-giving medicines could be affected. This proposed rule is dangerous and unethical: It does not save costs to Medicare and it does not save lives. 202-224-3121 Urge Congress to Protect Patients by Preserving Protected Classes in Medicare Part D. HIV AAHIVM, the nation’s leading organization of HIV care providers, strongly opposes any policy adjustment that weakens or disrupts providers’ ability to prescribe the right medications for HDFK RI WKHLU SDWLHQWV DV ZHOO DV WKH HVVHQWLDO GUXJV LQ WKH RWKHU ͤYH SURWHFWHG FODVVHV Paid for by American Academy of HIV Medicine.

© PressReader. All rights reserved.